PL2512453T3 - Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania - Google Patents

Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania

Info

Publication number
PL2512453T3
PL2512453T3 PL10793226T PL10793226T PL2512453T3 PL 2512453 T3 PL2512453 T3 PL 2512453T3 PL 10793226 T PL10793226 T PL 10793226T PL 10793226 T PL10793226 T PL 10793226T PL 2512453 T3 PL2512453 T3 PL 2512453T3
Authority
PL
Poland
Prior art keywords
pellets
manufacture
equipment
methods
pharmaceutical preparations
Prior art date
Application number
PL10793226T
Other languages
English (en)
Other versions
PL2512453T5 (pl
Inventor
Carsten Hoeg-Moller
Crilles Casper Larsen
Jorgen Wittendorff
Brigitte Nissen
Kenneth Manby Pedersen
Tue Hansen
Helle Poulsen
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42110308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2512453(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL2512453T3 publication Critical patent/PL2512453T3/pl
Publication of PL2512453T5 publication Critical patent/PL2512453T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10793226.1T 2009-12-18 2010-12-15 Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania PL2512453T5 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09179877A EP2340812A1 (en) 2009-12-18 2009-12-18 Granules for pharmaceutical preparations, methods and apparatus for their production
PCT/EP2010/069733 WO2011073245A2 (en) 2009-12-18 2010-12-15 Granules for pharmaceutical preparations, methods and apparatus for their production

Publications (2)

Publication Number Publication Date
PL2512453T3 true PL2512453T3 (pl) 2017-03-31
PL2512453T5 PL2512453T5 (pl) 2025-07-07

Family

ID=42110308

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10793226.1T PL2512453T5 (pl) 2009-12-18 2010-12-15 Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania

Country Status (28)

Country Link
US (2) US8765185B2 (pl)
EP (2) EP2340812A1 (pl)
JP (1) JP5593396B2 (pl)
KR (1) KR101882880B1 (pl)
CN (2) CN102791257B (pl)
AR (1) AR079536A1 (pl)
AU (1) AU2010332884B2 (pl)
BR (1) BR112012014935B1 (pl)
CA (1) CA2784235C (pl)
DK (1) DK2512453T4 (pl)
ES (1) ES2612870T5 (pl)
FI (1) FI2512453T4 (pl)
HR (1) HRP20161639T4 (pl)
HU (1) HUE031228T2 (pl)
IL (1) IL220319A (pl)
JO (1) JO3762B1 (pl)
LT (1) LT2512453T (pl)
MX (2) MX2012006851A (pl)
NL (1) NL1038373C2 (pl)
NZ (1) NZ600582A (pl)
PL (1) PL2512453T5 (pl)
PT (1) PT2512453T (pl)
RS (1) RS55438B2 (pl)
RU (1) RU2584349C2 (pl)
SI (1) SI2512453T2 (pl)
TW (1) TWI511723B (pl)
WO (1) WO2011073245A2 (pl)
ZA (1) ZA201204441B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
SMT202400116T1 (it) 2008-10-02 2024-05-14 Salix Pharmaceuticals Ltd Trattamento dell’encefalopatia epatica utilizzando rifaximina
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
DE202017102645U1 (de) * 2017-05-03 2018-08-06 Romaco Kilian Gmbh Ablaufvorrichtung für Presslinge einer Rundläufer-Tablettenpresse sowie Rundläufer-Tablettenpresse mit Ablaufvorrichtung
RU2667637C1 (ru) * 2017-06-26 2018-09-21 Гермес Арцнаймиттель ГмбХ Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом
ES2938608T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Método para preparar una forma farmacéutica sólida que comprende anticuerpos mediante granulación en húmedo, extrusión y esferonización
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
ES2938609T3 (es) 2017-09-20 2023-04-13 Tillotts Pharma Ag Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión
KR102161235B1 (ko) * 2020-07-22 2020-09-29 주식회사 피티케이 이송 일체형 과립 제조 장치 및 방법
US20240032570A1 (en) * 2020-08-18 2024-02-01 Uha Mikakuto Co., Ltd. Oral fast-disintegrating solid food and method for manufacturing same
CN114472139A (zh) * 2022-01-04 2022-05-13 安徽宏信药业发展有限公司 一种中药药丸干燥筛选装置
CN115445902B (zh) * 2022-09-21 2023-06-06 重庆科技学院 一种条形颗粒物三维尺寸分选方法及装置
WO2024200722A1 (en) 2023-03-28 2024-10-03 Tillotts Pharma Ag Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract
CN116942532B (zh) * 2023-09-20 2023-12-12 北京爱力佳医药科技有限公司 一种粉状药物制备装置

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4720473A (en) * 1986-03-10 1988-01-19 Cri International, Inc. Production of improved catalyst-type particles using length and density grading
DE3786544T2 (de) * 1986-03-10 1994-02-03 Cri Int Inc Verfahren zur Sortierung und Isolierung von Katalysator-Formteilchen nach ihrer Länge.
JPH0827133B2 (ja) 1993-07-13 1996-03-21 不二パウダル株式会社 湿潤粉粒体の処理装置
US6004581A (en) * 1995-12-21 1999-12-21 Farmaceutisk Laboratorium Ferring A/S Modified release oral pharmaceutical composition and method for the treatment of bowel diseases
KR100542544B1 (ko) 1995-12-21 2006-05-10 파마슈티스크 라보라토리움 페링 에이/에스 5-아미노살리실산을함유하는방출제어형경구용약제학적조성물및장질환을치료하는방법
AUPO637197A0 (en) 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DE19724181A1 (de) * 1997-06-09 1998-12-10 Bayer Ag Multiple-unit-retard-Zubereitungen und Verfahren zu ihrer Herstellung
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6146685A (en) 1998-11-05 2000-11-14 Delsys Pharmaceutical Corporation Method of deposition a dry powder and dispensing device
AU764469B2 (en) * 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
US6735487B1 (en) 1999-07-01 2004-05-11 Ods Properties, Inc. Interactive wagering system with promotions
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US8282955B2 (en) 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
PT1441700E (pt) 2001-10-15 2007-10-29 Ferring Bv Método para a preparação de uma composição compreendendo ácido 5-aminosalicílico para uso em tratamento de colites ulcerosas ou da doença de crohn
US7445796B2 (en) 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1470819A1 (en) * 2003-04-23 2004-10-27 Ferring B.V. High drug load mesalazine sachet
EP1547601A1 (en) * 2003-12-23 2005-06-29 Ferring B.V. Coating method
US7207505B2 (en) 2004-06-04 2007-04-24 Bender Martin P Method for producing small granules
DE102004028977A1 (de) * 2004-06-16 2006-01-05 Add Advanced Drug Delivery Technologies Ltd. Neutralpellets
JP2009521402A (ja) 2005-11-17 2009-06-04 テバ ファーマシューティカル インダストリーズ リミティド プロパルギル化アミノインダンの分離のための方法
EP2340812A1 (en) 2009-12-18 2011-07-06 Ferring International Center S.A. Granules for pharmaceutical preparations, methods and apparatus for their production

Also Published As

Publication number Publication date
WO2011073245A2 (en) 2011-06-23
DK2512453T3 (en) 2017-01-09
TWI511723B (zh) 2015-12-11
PT2512453T (pt) 2016-12-16
JP2013514312A (ja) 2013-04-25
ES2612870T5 (en) 2025-05-09
MX2012006851A (es) 2012-08-31
NZ600582A (en) 2014-09-26
KR101882880B1 (ko) 2018-07-27
ZA201204441B (en) 2013-02-27
AR079536A1 (es) 2012-02-01
US20140328934A1 (en) 2014-11-06
AU2010332884A1 (en) 2012-07-05
TW201125556A (en) 2011-08-01
ES2612870T3 (es) 2017-05-19
EP2512453B1 (en) 2016-11-09
WO2011073245A3 (en) 2011-08-11
HUE031228T2 (en) 2017-07-28
SI2512453T1 (sl) 2017-02-28
PL2512453T5 (pl) 2025-07-07
CA2784235A1 (en) 2011-06-23
FI2512453T4 (fi) 2025-05-23
NL1038373C2 (en) 2011-06-21
CN105769772A (zh) 2016-07-20
CA2784235C (en) 2019-01-15
BR112012014935A2 (pt) 2016-03-08
SI2512453T2 (sl) 2025-06-30
KR20120102775A (ko) 2012-09-18
RS55438B1 (sr) 2017-04-28
RU2584349C2 (ru) 2016-05-20
MX351365B (es) 2017-10-12
DK2512453T4 (da) 2025-06-02
JP5593396B2 (ja) 2014-09-24
IL220319A0 (en) 2012-08-30
CN102791257A (zh) 2012-11-21
EP2340812A1 (en) 2011-07-06
HRP20161639T1 (hr) 2017-02-10
LT2512453T (lt) 2016-12-27
EP2512453A2 (en) 2012-10-24
AU2010332884B2 (en) 2015-12-10
US8765185B2 (en) 2014-07-01
IL220319A (en) 2016-03-31
HRP20161639T4 (hr) 2025-06-20
CN102791257B (zh) 2017-03-01
RS55438B2 (sr) 2025-06-30
RU2012124834A (ru) 2014-01-27
US9114083B2 (en) 2015-08-25
BR112012014935B1 (pt) 2021-12-21
FI2512453T9 (fi) 2025-06-13
JO3762B1 (ar) 2021-01-31
EP2512453B2 (en) 2025-03-12
US20130022681A1 (en) 2013-01-24

Similar Documents

Publication Publication Date Title
IL263904A (en) Dose counters for inhalers and inhalers and shafts thereof
PL2512453T5 (pl) Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania
IL253870A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
IL243932A0 (en) Certain chemical entities, compositions and methods
HUE062860T2 (hu) Magas koncentrációjú gyógyszerészeti készítmények
DK3354665T5 (da) Modificerede alginater til celleindkapsling og celleterapi
DK3622883T3 (da) Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger
IL222465A0 (en) Certain amino-pyridazines, compositions thereof, and methods for their use
DK2729151T3 (da) Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf
IL224976A (en) Converted history of 1h - indazole and a pharmaceutical preparation containing them
BR112013010725A2 (pt) método, e, composição
PL3564361T3 (pl) Organoid wątroby, jego zastosowanie i sposoby hodowlane jego otrzymywania
HRP20150926T4 (hr) Pripravci u krutom stanju
IL225597A0 (en) Pharmaceutical preparation, methods of treatment and its uses
IL222930B (en) Chlorotoxin variants, conjugates and methods for their use
BR112013013584A2 (pt) endoscópio, e, método
DK2571624T3 (da) Multifysisk brændstofforstøver og fremgangsmåder
DK2584921T3 (da) Sondeernæringspakninger og fremgangsmåder til anvendelse deraf
IL223463A (en) Urea History, Pharmaceutical Preparations Containing and Uses
GT201200303A (es) Formulaciones farmacéuticas
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
DK2544986T3 (da) System og fremgangsmåde til aseptisk dosering
DK2591123T4 (da) Fodertilskud til et enmavet dyr, anvendelse og fremgangsmåde til fremstilling deraf